Richard Champlin

2.7k citations
52 papers · 1.7k · 1 hit paper · h-index 19

Impact in

  • Hematology top 0.5%
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments

Papers in

    • Hematopoietic Stem Cell Transplantation 22
    • Acute Myeloid Leukemia Research 14
    • Multiple Myeloma Research and Treatments 9
    • Chronic Myeloid Leukemia Treatments 6
    • Cancer Treatment and Pharmacology 5

Richard Champlin

51 papers receiving 1.6k citations

Richard Champlin's Hit Papers

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study 2012 · 310 citations
3100+4+9Years since publication100200300

Peers

Richard Champlin
Comparison fields: 5 of 90
  • Hematology 987
  • Transplantation 58
  • Oncology 548
  • Genetics 167
  • Public Health, Environmental and Occupational Health 388
Replace Noga Shem‐Tov with:
Noga Shem‐Tov Israel
J Cahn France
Appelbaum Fr United States
Jean‐Pierre Jouet France
Taiga Nishihori United States
Jean El Cheikh France
Boglarka Gyurkocza United States
Betty K. Hamilton United States
D I Marks United Kingdom
Andrew R. Rezvani United States
Richard Champlin relative to Noga Shem‐Tov Israel Noga Shem‐Tov's profile →
Citations per field
00.5×1.5×
Noga Shem‐Tov · 1×
Citations per year

Countries citing papers authored by Richard Champlin

Since Specialization
Citations

This map shows the geographic impact of Richard Champlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Champlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Champlin more than expected).

Fields of papers citing papers by Richard Champlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Champlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Champlin. The network helps show where Richard Champlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard Champlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard Champlin Line = papers co-authored together Richard Champlin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
Hit paper breakdown →
2012310
2 2002173
3 2004150
4 2002110
5 200384
6 200984
7 201276
8 200775
9 199966
10 199556
11 201148
12 201140
13 199235
14 199328
15 201326
16 200723
17 200423
18 201322
19 199822
20 200517

About Richard Champlin

Richard Champlin is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Genetics and Molecular Biology, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (22 papers), Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (13 papers), Multiple Myeloma Research and Treatments (9 papers), Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). The work is most often cited by research in Hematology (987 citations), Transplantation (58 citations), Oncology (548 citations), Genetics (167 citations) and Public Health, Environmental and Occupational Health (388 citations). Richard Champlin has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Sergio Giralt, Issa F. Khouri, Chitra Hosing, Raymond Alexanian, Marcos de Lima, Partow Kebriaei, Rima M. Saliba, Jeffrey J. Molldrem, Börje S. Andersson and Cindy Ippoliti. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, American Journal of Hematology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact